Browsing Tag
Gozellix
3 posts
Telix Pharmaceuticals (ASX: TLX) revenue tops $247m as pipeline spending rises
Telix Pharmaceuticals revenue is accelerating, but rising R&D spending and FDA decisions will determine whether ASX: TLX can regain its premium.
Telix Pharmaceuticals (ASX: TLX) jumps 16% after CMS greenlight and Illuccix’s European rollout
Telix Pharmaceuticals raises FY25 revenue guidance after securing CMS reimbursement for Gozellix and accelerating Illuccix's launch in Europe. Learn what’s next.
Telix Pharmaceuticals gains U.S. Medicare reimbursement code for Gozellix prostate cancer imaging agent
Telix Pharmaceuticals’ Gozellix secures U.S. reimbursement code, opening access to PSMA-PET prostate cancer imaging. Find out what’s next for its rollout and impact.